Lessons from the past

Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies

Melissa M. Hudson, Joseph P. Neglia, William G. Woods, John T. Sandlund, Ching Hon Pui, Larry E. Kun, Leslie L. Robison, Daniel M. Green

Research output: Contribution to journalReview article

64 Citations (Scopus)

Abstract

Investigations of long-term outcomes have been instrumental in designing safer and more effective contemporary therapies for pediatric hematological malignancies. Despite the significant therapeutic changes that have occurred over the last five decades, therapy modifications largely represent refinements of treatment protocols using agents and modalities that have been available for more than 30 years. This review summarizes major trends in the evolution of treatment of pediatric hematological malignancies since 1960 to support the relevance of the study of late effects of historical therapeutic approaches to the design and evaluation of contemporary treatment protocols and the follow-up of present-day survivors.

Original languageEnglish (US)
Pages (from-to)334-343
Number of pages10
JournalPediatric Blood and Cancer
Volume58
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Hematologic Neoplasms
Pediatrics
Clinical Protocols
Neoplasms
Therapeutic Uses
Therapeutics

Keywords

  • Childhood cancer therapy
  • Late effects
  • Long-term follow-up

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Lessons from the past : Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. / Hudson, Melissa M.; Neglia, Joseph P.; Woods, William G.; Sandlund, John T.; Pui, Ching Hon; Kun, Larry E.; Robison, Leslie L.; Green, Daniel M.

In: Pediatric Blood and Cancer, Vol. 58, No. 3, 01.03.2012, p. 334-343.

Research output: Contribution to journalReview article

Hudson, Melissa M. ; Neglia, Joseph P. ; Woods, William G. ; Sandlund, John T. ; Pui, Ching Hon ; Kun, Larry E. ; Robison, Leslie L. ; Green, Daniel M. / Lessons from the past : Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. In: Pediatric Blood and Cancer. 2012 ; Vol. 58, No. 3. pp. 334-343.
@article{408048fc937d4eefa6c70cdcaddeff88,
title = "Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies",
abstract = "Investigations of long-term outcomes have been instrumental in designing safer and more effective contemporary therapies for pediatric hematological malignancies. Despite the significant therapeutic changes that have occurred over the last five decades, therapy modifications largely represent refinements of treatment protocols using agents and modalities that have been available for more than 30 years. This review summarizes major trends in the evolution of treatment of pediatric hematological malignancies since 1960 to support the relevance of the study of late effects of historical therapeutic approaches to the design and evaluation of contemporary treatment protocols and the follow-up of present-day survivors.",
keywords = "Childhood cancer therapy, Late effects, Long-term follow-up",
author = "Hudson, {Melissa M.} and Neglia, {Joseph P.} and Woods, {William G.} and Sandlund, {John T.} and Pui, {Ching Hon} and Kun, {Larry E.} and Robison, {Leslie L.} and Green, {Daniel M.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1002/pbc.23385",
language = "English (US)",
volume = "58",
pages = "334--343",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Lessons from the past

T2 - Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies

AU - Hudson, Melissa M.

AU - Neglia, Joseph P.

AU - Woods, William G.

AU - Sandlund, John T.

AU - Pui, Ching Hon

AU - Kun, Larry E.

AU - Robison, Leslie L.

AU - Green, Daniel M.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Investigations of long-term outcomes have been instrumental in designing safer and more effective contemporary therapies for pediatric hematological malignancies. Despite the significant therapeutic changes that have occurred over the last five decades, therapy modifications largely represent refinements of treatment protocols using agents and modalities that have been available for more than 30 years. This review summarizes major trends in the evolution of treatment of pediatric hematological malignancies since 1960 to support the relevance of the study of late effects of historical therapeutic approaches to the design and evaluation of contemporary treatment protocols and the follow-up of present-day survivors.

AB - Investigations of long-term outcomes have been instrumental in designing safer and more effective contemporary therapies for pediatric hematological malignancies. Despite the significant therapeutic changes that have occurred over the last five decades, therapy modifications largely represent refinements of treatment protocols using agents and modalities that have been available for more than 30 years. This review summarizes major trends in the evolution of treatment of pediatric hematological malignancies since 1960 to support the relevance of the study of late effects of historical therapeutic approaches to the design and evaluation of contemporary treatment protocols and the follow-up of present-day survivors.

KW - Childhood cancer therapy

KW - Late effects

KW - Long-term follow-up

UR - http://www.scopus.com/inward/record.url?scp=84855801388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855801388&partnerID=8YFLogxK

U2 - 10.1002/pbc.23385

DO - 10.1002/pbc.23385

M3 - Review article

VL - 58

SP - 334

EP - 343

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -